Λιθουανία -
Λιθουανικά -
SMCA (Valstybinė vaistų kontrolės tarnyba)
dexamethasone krka
lex ano, uab - deksametazonas - tabletės - 4 mg - dexamethasone
Λιθουανία -
Λιθουανικά -
SMCA (Valstybinė vaistų kontrolės tarnyba)
nodexon
norameda, uab - deksametazonas - tabletės - 4 mg - dexamethasone
Λιθουανία -
Λιθουανικά -
SMCA (Valstybinė vaistų kontrolės tarnyba)
nodexon
norameda, uab - deksametazonas - tabletės - 8 mg - dexamethasone
Λιθουανία -
Λιθουανικά -
SMCA (Valstybinė vaistų kontrolės tarnyba)
nodexon
norameda, uab - deksametazonas - tabletės - 20 mg - dexamethasone
Ευρωπαϊκή Ένωση -
Λιθουανικά -
EMA (European Medicines Agency)
brukinsa
beigene ireland ltd - zanubrutinib - waldenstrom macroglobulinemia - antinavikiniai vaistai - brukinsa as monotherapy is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo-immunotherapy. brukinsa as monotherapy is indicated for the treatment of adult patients with marginal zone lymphoma (mzl) who have received at least one prior anti-cd20-based therapy. brukinsa as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukemia (cll).
Λιθουανία -
Λιθουανικά -
SMCA (Valstybinė vaistų kontrolės tarnyba)
dexamethasone krka
lex ano, uab - deksametazonas - tabletės - 8 mg - dexamethasone
Λιθουανία -
Λιθουανικά -
SMCA (Valstybinė vaistų kontrolės tarnyba)
dexamethasone krka
lex ano, uab - deksametazonas - tabletės - 20 mg - dexamethasone
Ευρωπαϊκή Ένωση -
Λιθουανικά -
EMA (European Medicines Agency)
lunsumio
roche registration gmbh - mosunetuzumab - limfoma, folikulai - antineoplastic agents, monoclonal antibodies - lunsumio as monotherapy is indicated for the treatment of adult patients with relapsed or refractory follicular lymphoma (fl) who have received at least two prior systemic therapies.
Ευρωπαϊκή Ένωση -
Λιθουανικά -
EMA (European Medicines Agency)
thalidomide lipomed
lipomed gmbh - talidomidas - daugybinė mieloma - imunosupresantai - thalidomide lipomed in combination with melphalan and prednisone is indicated as first line treatment of patients with untreated multiple myeloma, aged ≥ 65 years or ineligible for high dose chemotherapy. thalidomide lipomed is prescribed and dispensed in accordance with the thalidomide lipomed pregnancy prevention programme (see section 4.
Λιθουανία -
Λιθουανικά -
SMCA (Valstybinė vaistų kontrolės tarnyba)
alkeran
niromed, uab - melfalanas - milteliai ir tirpiklis injekciniam tirpalui - 50 mg - melphalan